hepatopathy

objective to observe the curative effect difference of alcoholic hepatopathy treated by routine treatment and combination of chinese traditional and western medicine.

目的观察用常规方法及中西医结合方法治疗酒精性肝病的疗效差异。

互联网摘选

As the effective method of treating terminal hepatic and biliary disease, chronic metabolism hepatopathy and liver tumor, liver transplantation has developed quickly.

作为治疗终末期肝胆疾病、先天并口代谢性肝病及肝肿瘤等的有效手段，肝移植得到迅猛发展。

互联网摘选

Semen litchi, one of Chinese herbal medicine commonly used, was mainly prescribed in treatment of hepatopathy.

荔枝核作为常用的中草药之一，主要用于治疗与肝脏相关的疾患。

互联网摘选

To summarise the morbidity, nosogenesis, and nursing care of chronic hepatopathy patients developed protein malnutrition.

对慢性肝病病人蛋白质能量营养不良的发生率、发生机制及其护理等进行综述。

互联网摘选

Conclusion: The serum fluorescence assay may be of great importance in the diagnosis of hepatopathy.

结论：不同肝病患者血清自体荧光光谱表现不同，测定血清自体荧光光谱有望对肝病进行鉴别诊断。

互联网摘选

The product is also used for hepatopathy anaemia, poisoning, sweeny, poliomyelitis, and psychopathy.

伴有胆汁分泌减少的肝病、贫血 、 中毒 、 肌萎缩症 、 脊髓灰质炎后遗症 、 神经及精神病.

网络文摘精选

Conclusions: The main clinical manifestation of hepatogenic diabetes is hepatopathy, and it's diabetic clinical symptoms is usually not typical. Higher BG after meal is the main feature of hepatogenic diabetes and insulin resistance ( IR) is basic-pathogeny.

结论：肝原性糖尿病的临床表现以肝病为主，糖尿病的临床症状多不典型，以餐后高血糖为特征，胰岛素抵抗是其基本机制；

互联网摘选

Objective To explore the efficacy of ribonucleic acid ( RNA) in the treatment of the chronic hepatopathy with hypoalbuminemia.

目的观察核糖核酸治疗慢性肝病低蛋白血症的疗效。

互联网摘选

57.14% ( 124/ 217) remained asymptomatic carrier, 73 transferred to chronic hepatopathy, the developing trend was from CHB to LC to HCC gradually. The transfer rate from AsC to LC and HCC per year was 1.04% and 0.40%.

57.14%（124/217例）仍保持无症状携带者状态，73例转化为慢性肝病呈CHB、LC、HCC逐渐演变趋势，每年AsC向LC、HCC的转化率分别为1.04%、0.40%。

互联网摘选

Conclusion: anethol trithione can improve the symptoms and liver functions without unbearable side-effects in the patients with chronic hepatopathy as well as the tiopronin dose.

结论；茴三硫治疗慢性病毒性肝炎、药物性肝炎等慢性肝损害，可以明显减轻患者症状，改善肝功能，其疗效与硫普罗宁效果相近，临床观察无明显不良反应。

互联网摘选

Results PBC was 59.68 % and AIH 40.32 % in the autoimmune hepatopathy.

结果自身免疫性肝病中PBC占59.68%,AIH40.32%.

互联网摘选